RXI PHARMACEUTIC

PHIO NASDAQ
0.4560
-0.0191
-4.02%
盘后: 0.4560 0 0.00% 17:56 05/17 EDT
开盘
0.4800
昨收
0.4751
最高
0.4800
最低
0.4550
成交量
19.99万
成交均量(3M)
67.99万
52周最高
2.580
52周最低
0.2700
换手率
0.90%
市值
1,016.84万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供RXI PHARMACEUTIC PHIO股票价格,RXI PHARMACEUTIC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) (sd-rxRNA) therapeutic platform. The Company’s focuses on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene targets, or to be used in immunotherapy following intratumoral injection. The Company’s pipeline include RXI-762 and RXI-804. Its sd-rxRNA compounds are designed to down-regulate the expression of a specific gene that may be over-expressed in a disease condition. The Company is developing RXI-762 for the treatment of Melanoma, Ovarian cancer and other indications. RXI-804 is an sd-rxRNA compound that is designed to suppress the expression of immune checkpoint protein, TIGIT.
展开 >

最近浏览

名称
价格
涨跌幅